Tag: Molecularly targeted therapy

Zodasiran siRNA Lowers Triglycerides and LDL Cholesterol in Phase 1 Trial

April 7, 2026

Zodasiran siRNA Lowers Triglycerides and LDL Cholesterol in Phase 1 Trial

Sirt1 Huntington’s Disease: Neuroprotection & Targets

November 27, 2025

Sirt1 Huntington’s Disease: Neuroprotection & Targets

Claudin18.2 Therapies: Evolution in Gastroesophageal Cancer

August 19, 2025

Claudin18.2 Therapies: Evolution in Gastroesophageal Cancer